Section 1 Enhance Regulatory Environment for Medicinal Product Management
Section 2 Reinforce Medicinal Product Digital Management and Risk Control
Section 3 Complete the Regulations for the Distribution of Medicinal Products
Section 4 Actively Participate in International Pharmaceutical Organizations
Section 5 Improvement of Drug Quality Analysis Technology
Section 6 Deepen the Medical Information Exchange of the New Southbound Policy |
本站僅提供期刊文獻檢索。
